Clinical utility and validity of the postoperation symptom inventory following lung cancer surgery_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

WANG Mingming , LI Xia ,  CHE Guowei , LIN Rongjia , ZHOU Kun , LI Pengfei , YANG Mei

Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding?author：

CHE Guowei, Email: guowei_che@yahoo.com

Keywords：

Symptom inventory; reliability and validity; lung cancer surgery

DOI：

10.7507/1007-4848.201703004

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To examine the clinical utility of postoperation symptom inventory. Methods According to the current cancer symptom assessment tools, clinical guidelines and expert interviews, we preliminarily selected 10 common symptoms as an alternative item. Postoperative symptom assessment scale of lung cancer patients was formulated through expert evaluation. And 383 patients in eight hospitals were evaluated and validated using the scale to analyze the reliability and validity. Results Postoperation symptom inventory was easy to operate and evaluate for postoperative lung cancer patients in 8 symptoms (pain, shortness of breath, fatigue, cough, insomnia, throat pain, sweating and constipation). The scale was with high reliability. Cronbach' s α was 0.888. This scale was also with reliable validity. Content validity index was 0.900. There were two common factors with high cumulative proportion in variance(47.70% and 57.46%). And each question had high factor load and communality (>0.40) in the exploratory factor analysis. Conclusion The postoperation symptom inventory has excellent reliability and validity in patients with lung cancer surgery.

Citation： WANG Mingming, LI Xia, CHE Guowei, LIN Rongjia, ZHOU Kun, LI Pengfei, YANG Mei. Clinical utility and validity of the postoperation symptom inventory following lung cancer surgery. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2017, 24(6): 417-422. doi: 10.7507/1007-4848.201703004 Copy

1.	車國衛, 李為民, 劉倫旭. 快速肺康復需要圍手術期流程優化. 中國胸心血管外科臨床雜志, 2016, 23(3): 216-220.
2.	車國衛, 劉倫旭, 石應康. 加速康復外科臨床應用現狀與思考. 中國胸心血管外科臨床雜志, 2016, 23(3): 211-215.
3.	鮑珊, 蘇建華, 廖虎, 等. 合并慢性阻塞性肺病和手術方式對肺癌患者術后快速康復及治療費用的影響. 中國胸心血管外科臨床雜志, 2014, 21(1): 17-20.
4.	Fagundes CP, Shi Q, Vaporciyan AA, et al. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg, 2015, 150(3): 613-619.
5.	Liu L, Che G, Pu Q, et al. A new concept of endoscopic lung cancer resection: Single -direction thoracoscopic lobectomy. Surg Oncol, 2010, 19(2): e71-77.
6.	Zhi XY, Yu JM, Shi YK. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version). Cancer, 2015, 121 (Suppl 17): 3165-3181.
7.	韓兆杰, 宋志芳, 蘇建華, 等. 單胸腔引流管在肺癌術后快速康復中的應用. 中國胸心血管外科臨床雜志, 2014, 21(1): 17-20.
8.	蘇建華, 周渝斌, 蒲強, 等. 影響肺癌手術住院費用和快速康復的臨床因素分析. 中國肺癌雜志, 2014, 17(7): 536-540.
9.	Wang XS, Wang Y, Guo H, et al. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer, 2004, 101(8): 1890-1901.
10.	Mendoza TR, Wang XS, Lu C, et al. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist, 2011, 16(2): 217-227.
11.	史靜琤, 莫顯昆, 孫振球. 量表編制中內容效度指數的應用. 中南大學學報(醫學版), 2012, 37(2): 49-52.
12.	關守義. 克龍巴赫 α 系數研究述評. 心理科學, 2009, 32(3): 685-687.
13.	孫曉軍. 探索性因子分析及其在應用中存在的主要問題. 心理科學, 2005, 28(6): 162-164.
14.	Roque H, Veloso A, Ferreira PL. Portuguese version of the EUROPEP questionnaire: contributions to the psychometric validation. Rev Saude Publica, 2016, 50(0): 61-67.
15.	許軍, 劉世霆, 胡敏燕, 等. 自測健康評定量表修訂版 (SRHMSV1.0) 的條目分析. 現代康復, 2001, 5(10): 58-59.
16.	李燦, 辛玲. 調查問卷的信度與效度的評價方法研究. 中國衛生統計, 2008, 25(5): 541-544.
17.	Shamieh O, Khamash O, Khraisat M, et al. Impact of outpatient palliative care(PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan.Support Care Cancer, 2017, 25(1): 177-183.
18.	Mendoza TR, Zhao F, Cleeland CS, et al.The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clin Breast Cancer, 2013, 13(5): 325-334.
19.	Lange RT, Brickell TA, et al. Clinical utility of the Neuro behavioral Symptom Inventory validity scales to screen for symptom exaggeration following traumatic brain injury. J Clin Exp Neuropsychol, 2015, 37(8): 853-862.

1. 車國衛, 李為民, 劉倫旭. 快速肺康復需要圍手術期流程優化. 中國胸心血管外科臨床雜志, 2016, 23(3): 216-220.
2. 車國衛, 劉倫旭, 石應康. 加速康復外科臨床應用現狀與思考. 中國胸心血管外科臨床雜志, 2016, 23(3): 211-215.
3. 鮑珊, 蘇建華, 廖虎, 等. 合并慢性阻塞性肺病和手術方式對肺癌患者術后快速康復及治療費用的影響. 中國胸心血管外科臨床雜志, 2014, 21(1): 17-20.
4. Fagundes CP, Shi Q, Vaporciyan AA, et al. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory. J Thorac Cardiovasc Surg, 2015, 150(3): 613-619.
5. Liu L, Che G, Pu Q, et al. A new concept of endoscopic lung cancer resection: Single -direction thoracoscopic lobectomy. Surg Oncol, 2010, 19(2): e71-77.
6. Zhi XY, Yu JM, Shi YK. Chinese guidelines on the diagnosis and treatment of primary lung cancer (2015 version). Cancer, 2015, 121 (Suppl 17): 3165-3181.
7. 韓兆杰, 宋志芳, 蘇建華, 等. 單胸腔引流管在肺癌術后快速康復中的應用. 中國胸心血管外科臨床雜志, 2014, 21(1): 17-20.
8. 蘇建華, 周渝斌, 蒲強, 等. 影響肺癌手術住院費用和快速康復的臨床因素分析. 中國肺癌雜志, 2014, 17(7): 536-540.
9. Wang XS, Wang Y, Guo H, et al. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer, 2004, 101(8): 1890-1901.
10. Mendoza TR, Wang XS, Lu C, et al. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist, 2011, 16(2): 217-227.
11. 史靜琤, 莫顯昆, 孫振球. 量表編制中內容效度指數的應用. 中南大學學報(醫學版), 2012, 37(2): 49-52.
12. 關守義. 克龍巴赫 α 系數研究述評. 心理科學, 2009, 32(3): 685-687.
13. 孫曉軍. 探索性因子分析及其在應用中存在的主要問題. 心理科學, 2005, 28(6): 162-164.
14. Roque H, Veloso A, Ferreira PL. Portuguese version of the EUROPEP questionnaire: contributions to the psychometric validation. Rev Saude Publica, 2016, 50(0): 61-67.
15. 許軍, 劉世霆, 胡敏燕, 等. 自測健康評定量表修訂版 (SRHMSV1.0) 的條目分析. 現代康復, 2001, 5(10): 58-59.
16. 李燦, 辛玲. 調查問卷的信度與效度的評價方法研究. 中國衛生統計, 2008, 25(5): 541-544.
17. Shamieh O, Khamash O, Khraisat M, et al. Impact of outpatient palliative care(PC) on symptom burden in patients with advanced cancer at a tertiary cancer center in Jordan.Support Care Cancer, 2017, 25(1): 177-183.
18. Mendoza TR, Zhao F, Cleeland CS, et al.The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group. Clin Breast Cancer, 2013, 13(5): 325-334.
19. Lange RT, Brickell TA, et al. Clinical utility of the Neuro behavioral Symptom Inventory validity scales to screen for symptom exaggeration following traumatic brain injury. J Clin Exp Neuropsychol, 2015, 37(8): 853-862.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Clinical utility and validity of the postoperation symptom inventory following lung cancer surgery

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content